Latest news Back to 'Institute of Cancer and Genomic Sciences' Young women in UK face unnecessary surgery for suspected appendicitis DescriptionThousands of young women are unnecessarily admitted to UK hospitals and undergo surgery they do not need each year in the NHS, a new study reveals.Date:04/12/2019 Leading neurosurgeon highlights importance of brain tumour research DescriptionProfessor Colin Watts, Chair of the Birmingham Brain Cancer Program, highlights the importance of brain tumour research.Date:25/10/2019 Anti-malarial drug can make cancer chemotherapy more effective DescriptionScientists at the University of Birmingham have found an anti-malarial drug was effective in treating head and neck cancer in mice.Date:25/09/2019 Birmingham researcher awarded 1st prize for oral presentation at prestigious annual scientific meeting DescriptionMonica Nafria, PhD student in the Institute of Cancer and Genomic Sciences, has been awarded 1st prize for best oral presentation at the International Society for Experimental Haematology annual meeting.Date:14/09/2019 Removing cancer's protective barrier could boost immunotherapy treatments DescriptionUniversity of Birmingham scientists may have found a way to pull down the protective wall that surrounds tumours, potentially re-exposing them to the killing power of the immune system and immunotherapy treatments.Date:27/08/2019 Birmingham collaboration awarded international MRC Newton Fund prostrate cancer grant DescriptionAn international team from the University of Birmingham and the University of Nottingham in the UK and the Kenya Medical Research Institute in Nairobi, Kenya, has been awarded £660,000 to study prostate cancer.Date:07/08/2019 Three Birmingham scientists awarded £4 million by Cancer Research UK DescriptionThree researchers from the University of Birmingham have been awarded more than £4 million by Cancer Research UK for their work to investigate new personalised cancer treatments.Date:07/08/2019 Hidden chemistry in flowers shown to kill cancer cells DescriptionResearchers at the University of Birmingham have shown that it's possible to produce a compound with anti-cancer properties directly from feverfew – a common flowering garden plant.Date:01/08/2019 Leading population geneticist is appointed Junior Group Leader DescriptionThe Institute of Cancer and Genomic Sciences recently appointed Dr Marc Haber as Junior Group Leader. He joins Birmingham from the Wellcome Sanger Institute bringing with him extensive experience in population genetics.Date:24/07/2019 Second Birmingham Symposium on Genome Structure and Function - 4th - 5th July 2019 DescriptionSecond Birmingham Symposium on Genome Structure and Function - 4th to 5th July 2019, Birmingham Centre for Genome BiologyDate:19/07/2019 Displaying 1 to 10 of 103 Previous 1 2 3 4 5 … Next